C12Y 101/0112
Galactose 1-dehydrogenase
Official title: Galactose 1-dehydrogenase (NADP+) (1.1.1.120)
C12Y101/0112 (Galactose 1-dehydrogenase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 1
- Inventors
- 4
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof25 Mar 2025US 12,257,284 B2Memorial Sloan Kettering Cancer Center
- Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof28 Dec 2021US 11,207,374 B2Memorial Sloan Kettering Cancer Center
- Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof8 Jan 2026US 2026/0007718 A1Memorial Sloan Kettering Cancer Center
- Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof24 Nov 2022US 2022/0370547 A1Memorial Sloan Kettering Cancer Center
- Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof26 Mar 2020US 2020/0093886 A1Memorial Sloan Kettering Cancer Center
Most cited
By later US patents